#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oesophageal atresia Pouchitis Polyneuropathy Metastases to central nervous system Small intestine neuroendocrine tumour Biotinidase deficiency Endometrial cancer recurrent Osteopetrosis Rosai-Dorfman syndrome Emphysema Neutropenia Immunoglobulin G4 related disease Peripheral primitive neuroectodermal tumour of soft tissue Cerebral amyloid angiopathy Thrombotic thrombocytopenic purpura More trials…

    Learn about Rare Diseases

    Splenic marginal zone lymphoma – Trials in Disease Brain stem glioma – Basic Information Mastocytosis – Life with Disease Glomerulonephritis membranous – Trials in Disease Soft tissue sarcoma – Treatment MELAS syndrome – Trials in Disease Haemophilia – Life with Disease Primary immunodeficiency syndrome – Treatment Haemolytic uraemic syndrome Propionic acidaemia – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Losartan Almagate Diphenhydramine Corylus Avellana L. Fluoxetine Hydrochloride Pirtobrutinib Soya Oil Litenimod Sodium Fluvastatin Sodium [Al[18F]F]Fapi-74 Isoleucine ANOC-001 LIGUFALIMAB M2Rlab Munc-Cd34 Mva-209-Fsp-B4 ENSIFENTRINE Metoprolol Gimeracil Lithium Sulphate, Anhydrous More therapies…

    Learn about Your Condition

    Fracture infection Tourette's disorder Paget's disease of the vulva Neoplasm Inner ear disorder Rectal cancer stage II Breast cancer in situ Lipid metabolism disorder Univentricular heart Nasal sinus cancer Alveolar bone defect Oedema Oesophageal atresia Hyponatraemia Neuromyopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of oral rilzabrutinib for adults with immune thrombocytopenia who did not respond to first-line treatment

    Recruiting

    3 1 1
    Investigated Drugs:
    • Rilzabrutinib
    Austria Czechia France Germany Hungary Italy +3

  • Study of ciltacabtagene autoleucel in patients with newly diagnosed multiple myeloma using a modified treatment preparation regimen

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Ciltacabtagene Autoleucel
    Spain

  • Study of budesonide, glycopyrronium and formoterol inhaler to evaluate heart and lung function in patients with chronic obstructive pulmonary disease and hyperinflation

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Formoterol Fumarate Dihydrate
    • Glycopyrronium Bromide
    • Budesonide
    Germany

  • Study comparing Sucrosomial Iron and Ferric Maltol treatment for women with iron deficiency

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Iron deficiency
    Spain

  • Study of testosterone supplementation to improve quality of life in male patients receiving palliative care who have androgen deficiency

    Recruiting

    2 1 1 1
    Belgium

  • Study comparing high-dose and low-dose aspirin with prasugrel and aspirin combination in patients after coronary artery bypass grafting surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Coronary artery disease
    • Chronic coronary syndrome
    Investigated Drugs:
    • Prasugrel
    • Acetylsalicylic Acid
    Poland
Previous Page
1 … 124 125 126 127 128 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!